Is any trial design description available? It’s non randomised I assume, couldn’t find anything on clinical trials.gov. Main Question is what standard of care is allowed in these c19 hospitalised patients because if discretionary and say steroids like dexa used, going to be hard to tease out what the idroxonil actually does, some potential confounders and small sample . This looks more like proof of concept trial that’ll need validation in RCT.
NOXCOVID, page-3
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
